| Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations AM Mandard, F Dalibard, JC Mandard, J Marnay, M Henry‐Amar, ... Cancer 73 (11), 2680-2686, 1994 | 2304 | 1994 |
| Consensus meeting for the management of gastrointestinal stromal tumors Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO JY Blay, S Bonvalot, P Casali, H Choi, M Debiec-Richter, AP Dei Tos, ... Annals of Oncology 16 (4), 566-578, 2005 | 1017 | 2005 |
| Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up PG Casali, N Abecassis, S Bauer, R Biagini, S Bielack, S Bonvalot, ... Annals of Oncology 29, iv51-iv67, 2018 | 863 | 2018 |
| Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up ESMO/European Sarcoma Network Working Group Annals of oncology: official journal of the European Society for Medical …, 2014 | 705 | 2014 |
| Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control S Bonvalot, M Rivoire, M Castaing, E Stoeckle, A Le Cesne, JY Blay, ... J Clin Oncol 27 (1), 31-7, 2009 | 682 | 2009 |
| Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up PG Casali, N Abecassis, S Bauer, R Biagini, S Bielack, S Bonvalot, ... Annals of Oncology 29, iv68-iv78, 2018 | 575 | 2018 |
| Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial PJ Woll, P Reichardt, A Le Cesne, S Bonvalot, A Azzarelli, HJ Hoekstra, ... The lancet oncology 13 (10), 1045-1054, 2012 | 560 | 2012 |
| Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group E Stoeckle, JM Coindre, S Bonvalot, G Kantor, P Terrier, F Bonichon, ... Cancer: interdisciplinary international journal of the American Cancer …, 2001 | 558 | 2001 |
| Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up PG Casali, S Bielack, N Abecassis, HT Aro, S Bauer, R Biagini, ... Annals of Oncology 29, iv79-iv95, 2018 | 522 | 2018 |
| Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial A Le Cesne, JY Blay, I Judson, A Van Oosterom, J Verweij, J Radford, ... Journal of Clinical Oncology 23 (3), 576-584, 2005 | 520 | 2005 |
| Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): a report on 1007 patients from the multi-institutional collaborative RPS working … A Gronchi, DC Strauss, R Miceli, S Bonvalot, CJ Swallow, P Hohenberger, ... Annals of surgery 263 (5), 1002-1009, 2016 | 501 | 2016 |
| Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ A Gronchi, AB Miah, AP Dei Tos, N Abecassis, J Bajpai, S Bauer, ... Annals of Oncology 32 (11), 1348-1365, 2021 | 481 | 2021 |
| Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity F Chibon, P Lagarde, S Salas, G Pérot, V Brouste, F Tirode, C Lucchesi, ... Nature medicine 16 (7), 781-787, 2010 | 458 | 2010 |
| Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment M Fiore, F Rimareix, L Mariani, J Domont, P Collini, C Le Péchoux, ... Annals of surgical oncology 16, 2587-2593, 2009 | 417 | 2009 |
| Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors NF Delahaye, S Rusakiewicz, I Martins, C Ménard, S Roux, L Lyonnet, ... Nature medicine 17 (6), 700-707, 2011 | 392 | 2011 |
| Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation S Salas, A Dufresne, B Bui, JY Blay, P Terrier, D Ranchere-Vince, ... J Clin Oncol 29 (26), 3553-3558, 2011 | 382 | 2011 |
| Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases J Fayette, E Martin, S Piperno-Neumann, A Le Cesne, C Robert, ... Annals of Oncology 18 (12), 2030-2036, 2007 | 382 | 2007 |
| An update on the management of sporadic desmoid-type fibromatosis: a European consensus initiative between sarcoma PAtients EuroNet (SPAEN) and European organization for … B Kasper, C Baumgarten, J Garcia, S Bonvalot, R Haas, F Haller, ... Annals of Oncology 28 (10), 2399-2408, 2017 | 378 | 2017 |
| Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft … D Callegaro, R Miceli, S Bonvalot, P Ferguson, DC Strauss, A Levy, ... The Lancet Oncology 17 (5), 671-680, 2016 | 372 | 2016 |
| NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act. In … S Bonvalot, PL Rutkowski, J Thariat, S Carrère, A Ducassou, MP Sunyach, ... The Lancet Oncology 20 (8), 1148-1159, 2019 | 361 | 2019 |
